India Eases China Investment Rules Amid 'Regulatory Cholesterol'
India’s Commerce Minister announced a gradual relaxation of restrictions on Chinese investment to support domestic manufacturing goals. However, analysts warn that foreign firms still face significant hurdles, including over 69,000 compliance rules, complex tariffs, and an average import clearance time of 30 days. This complex environment complicates India's positioning as a "China plus one" manufacturing alternative.
- The investment screening framework being relaxed, known as "Press Note 3," was instituted in April 2020 to prevent opportunistic takeovers of Indian firms during the pandemic and amid heightened border tensions with China. It mandated prior government approval for any foreign direct investment from countries sharing a land border with India. - The term "regulatory cholesterol" refers to a universe of 1,536 laws and 69,233 compliances that businesses in India must navigate. This includes 26,134 clauses that carry potential terms of imprisonment for violations. - A typical manufacturing MSME in a single state faces over 1,450 regulatory obligations annually, with compliance costs estimated between ₹13 to ₹17 lakh (approximately $15,600 to $20,400). Labor laws alone account for two-thirds of all compliance clauses linked to potential imprisonment. - This policy shift occurs even as bilateral frictions continue; in 2020, a deadly clash occurred between Indian and Chinese troops in the Galwan Valley, and China has more recently banned exports of rare earth magnets vital to India's auto industry. - Despite political tensions, India-China bilateral trade reached a record $136.2 billion in 2023, with India's trade deficit with China standing at $48.66 billion in the 2019-20 fiscal year. - The easing of rules is intended to support India's goal of increasing the manufacturing sector's share of GDP to 25% and growing its output to $1 trillion by the 2025-26 fiscal year. - According to Commerce and Industry Minister Piyush Goyal, the relaxation will be a "calibrated" and "step-by-step" process, with the immediate government focus on accelerating the approval process for Chinese investments rather than eliminating it entirely.
